Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years.
Dören
Martina
M
D000284:Administration, Oral; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004361:Drug Tolerance; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced*; D013997:Time Factors